TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CGEM

Cullinan Oncology LLC

Healthcare · Biotechnology

21.10$ -1.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement CGEM
Line item 2013 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0%
0.3% 0.3%
-0.3% 100.0%
228.1% 304.9%
90.4% 153.9%
318.5% 458.7%
-318.5% -358.7%
4.7% 345.5%
-313.9% -356.3%
-45.4% -12.9%
-268.4% -343.3%
-318.2% -358.4%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?